MAP E.coli

Methionine Aminopeptidase E.Coli Recombinant
Shipped with Ice Packs
In Stock

Description

Methionine Aminopeptidase (MAP)

MAP is a metalloenzyme encoded by the map gene in E. coli. It catalyzes the removal of N-terminal methionine residues from nascent proteins, a vital step in protein maturation.

Genetic and Biochemical Characteristics

PropertyDetailsReference
Gene locationmap gene (264 codons)
Enzyme structureMonomeric, 29.3 kDa, requires metal ions (e.g., Co²⁺) for activity
Substrate specificityCleaves methionine only if adjacent residues permit (e.g., small, uncharged)
Functional rolePost-translational protein modification, essential for cell viability

Key Findings:

  • MAP activity is critical for processing recombinant proteins like interleukin-2 and ricin A .

  • Substrate specificity depends on residues adjacent to methionine, influencing cleavage efficiency .

Map Effector Protein in Pathogenic E. coli

The Map (mitochondria-associated protein) effector is produced by enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC). It disrupts host cell functions during infection.

Role in Infection

FunctionMechanismReference
Tight junction disruptionInhibits recruitment of junctional proteins (e.g., ZO-1, occludin)
Mitochondrial targetingInduces mitochondrial dysfunction, contributing to cell death
Colonization maintenanceSuppression of map expression correlates with reduced bacterial load

Expression Dynamics:

  • Map expression peaks early in infection (≤1 day) but is suppressed by day 4, coinciding with reduced EPEC colonization .

  • Competitive colonization assays confirm Map’s role in sustaining infection .

Comparative Analysis of MAP Functions

AspectMethionine Aminopeptidase (MAP)Map Effector Protein
Gene/Proteinmap gene; metabolic enzymemap gene; virulence factor
Biological RoleProtein maturationHost cell disruption, pathogenicity
Expression ContextConstitutive in all E. coli strainsInduced in EPEC/EHEC during infection
Therapeutic RelevancePotential antibiotic target (metabolic inhibition)Vaccine/drug target (anti-virulence)

Research Implications

  1. Biotechnology: MAP’s role in protein processing aids recombinant protein production .

  2. Antimicrobial Strategies: Targeting Map effector activity could mitigate EPEC/EHEC infections .

  3. Evolutionary Adaptation: Dual roles of the map gene highlight E. coli’s genomic plasticity .

Product Specs

Introduction
Methionine aminopeptidases, categorized as peptidase M proteins, are members of the M24 protein family. These enzymes play a crucial role in post-translational modification by removing the initiator methionine residue from newly synthesized polypeptide chains. The active site of MAP contains two adjacent divalent metal ions bridged by a water molecule or a hydroxide ion.
Description
Produced in E. coli, this MAP is a single, non-glycosylated polypeptide chain composed of 284 amino acids (specifically, amino acids 1 to 264). It possesses a molecular weight of 31.5 kDa. For purification and detection purposes, a 20 amino acid His-tag is fused to the N-terminus of the MAP protein. The purification process involves proprietary chromatographic techniques.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The MAP protein is provided in a solution containing 1 mg/ml of the protein in a buffer composed of 20 mM Tris-HCl at a pH of 8.0, 10% glycerol, and 2 mM DTT.
Stability
For optimal storage, maintain the MAP protein at 4°C if the entire vial's contents will be used within 2 to 4 weeks. For extended storage, freeze the protein solution at -20°C. To further enhance stability during long-term storage, consider adding a carrier protein such as 0.1% HSA or BSA. It is crucial to minimize the number of freeze-thaw cycles to prevent protein degradation.
Purity
The purity of the MAP protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Methionine aminopeptidase, MAP, Peptidase M, map, b0168, JW0163.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAISIKTPED IEKMRVAGRL AAEVLEMIEP YVKPGVSTGE LDRICNDYIV NEQHAVSACL GYHGYPKSVC ISINEVVCHG IPDDAKLLKD GDIVNIDVTV IKDGFHGDTS KMFIVGKPTI MGERLCRITQ ESLYLALRMV KPGINLREIG AAIQKFVEAE GFSVVREYCG HGIGRGFHEE PQVLHYDSRE TNVVLKPGMT FTIEPMVNAG KKEIRTMKDG WTVKTKDRSL SAQYEHTIVV TDNGCEILTL RKDDTIPAII SHDE.

Q&A

What are the critical temperature thresholds for E.coli inactivation in laboratory studies?

The thermal inactivation of E.coli follows specific temperature-dependent kinetics that researchers must understand when designing experiments. E.coli begins to be inactivated at 140°F (60°C), with destruction rates increasing significantly at higher temperatures . For research protocols, consider:

  • At 140°F: Initial inactivation occurs, requiring extended exposure time

  • At 160°F: Rapid inactivation occurs within minutes

  • Higher temperatures accelerate destruction rates substantially

It's methodologically important to note that even after thermal destruction of E.coli cells, toxins may remain bioactive in experimental samples, as E.coli is a toxin producer . This presents significant considerations for designing thermal inactivation studies and interpreting results.

When implementing thermal inactivation protocols, researchers should establish clear time-temperature parameters and validate inactivation through culture-based confirmation rather than assuming complete destruction based solely on exposure parameters.

How do researchers differentiate between contamination sources when investigating E.coli outbreaks?

Methodologically sound source attribution requires systematic evaluation of potential contamination vectors. When investigating outbreaks, researchers must consider:

  • Food matrix analysis: Different food components carry varying risks (raw vegetables versus cooked meat)

  • Cross-contamination pathways: Transfer mechanisms between food items

  • Processing interventions: Efficacy of control measures at different production stages

Current research suggests that many E.coli outbreaks involve contaminated vegetables rather than properly cooked meat products, as demonstrated in multiple outbreaks where secondary ingredients (onions, lettuce, pickles) were implicated . Methodologically, researchers should employ:

  • Parallel testing of all potential sources

  • Molecular typing to match clinical and food isolates

  • Detailed food preparation workflow analysis

  • Statistical analysis of case-control consumption patterns

This multi-faceted approach allows for discrimination between primary contamination sources and secondary vectors in complex outbreak scenarios.

How can researchers design systematic chemical-chemical interaction studies for E.coli growth inhibition?

Designing robust chemical interaction studies requires a structured methodological framework. For comprehensive analysis of chemical-chemical interactions affecting E.coli, implement:

  • Systematic checkerboard assays with concentration-dependent analysis

  • Standardized growth conditions using defined media (e.g., M9 minimal medium)

  • Clear classification criteria for synergistic, antagonistic, or indifferent interactions

  • Comprehensive compound selection targeting diverse cellular pathways

A methodologically sound approach involves testing chemical probes systematically across multiple targets. Recent research demonstrated this by evaluating 45 compounds (990 unique combinations) that probe bacterial functions in nutrient synthesis and housekeeping functions .

Interaction TypeNumber ObservedPercentage of Total
Synergistic8344.6%
Antagonistic6233.3%
Indifferent4122.1%
Total186100%

When designing such studies, control for:

  • Solvent effects through appropriate vehicle controls

  • Growth phase variations by standardizing inoculation procedures

  • Medium-specific effects by including nutrient supplementation controls

  • Technical variation through sufficient biological and technical replicates

This systematic methodology enables identification of previously uncharacterized interactions between compounds affecting different cellular processes.

What methodologies are most effective for studying pathway-specific inhibition in E.coli under nutrient limitation?

Investigating pathway-specific inhibition under nutrient limitation requires integrated methodological approaches that combine:

  • Selective chemical probes targeting specific biosynthetic steps

  • Genetic validation using knockout or complementation strategies

  • Metabolic profiling to monitor pathway intermediates

  • Growth phenotyping under controlled nutrient availability

Research demonstrates the effectiveness of this approach in elucidating cross-pathway interactions. For example, L-norleucine inhibits methionine adenosyltransferase (MetK), preventing S-adenosylmethionine (SAM) production, which is required for the first biotin biosynthetic step . When combined with MAC13772 (an inhibitor of a late biotin biosynthesis step), researchers observed synergistic growth inhibition that revealed pathway interconnections.

The methodological workflow should include:

  • Preliminary characterization of individual inhibitor effects

  • Dose-response analysis under varying nutrient conditions

  • Supplementation studies with pathway end-products

  • Temporal analysis of inhibition effects

This integrated approach enables researchers to map complex metabolic networks and identify vulnerabilities specific to nutrient-limited conditions relevant to infection environments.

What statistical approaches should researchers employ when analyzing geographic distribution patterns of E.coli outbreaks?

Robust statistical analysis of outbreak geographic distribution requires:

  • Spatial cluster detection methods (e.g., spatial scan statistics)

  • Demographic normalization to account for population density variations

  • Time-series analysis to track directional spread

  • Supply chain network analysis for commercial product outbreaks

The recent multi-state E.coli outbreak linked to fast-food products demonstrates the importance of geographic analysis, as cases clustered predominantly in western states including Colorado, Wyoming, Montana, Nebraska, and others .

When designing geospatial analyses, researchers should:

  • Establish appropriate denominators for rate calculations

  • Account for reporting biases between jurisdictions

  • Consider environmental factors influencing pathogen survival

  • Integrate distribution network data for commercial products

This methodological framework enables differentiation between random case distribution and significant geographical clustering, providing critical insights for outbreak source identification.

How should researchers design experiments to distinguish between environmental persistence versus active transmission in E.coli outbreaks?

Discriminating between environmental persistence and ongoing transmission requires carefully designed experimental approaches:

  • Whole genome sequencing with high-resolution phylogenetic analysis

  • Temporal sampling to establish genetic drift rates

  • Environmental sampling protocols with sensitivity controls

  • Experimental models of environmental persistence under relevant conditions

Methodologically, researchers must implement:

  • Standardized sampling procedures across timepoints

  • Molecular clock analysis to estimate divergence timing

  • Matched clinical-environmental sampling

  • Controlled persistence studies mimicking outbreak conditions

This approach enables determination of whether new cases result from continued exposure to a persistent environmental reservoir or represent ongoing person-to-person or food-to-person transmission events, which has significant implications for intervention strategies.

What methodological approaches are most effective for investigating biotin biosynthesis inhibition in E.coli?

Investigation of biotin biosynthesis inhibition requires specific methodological considerations:

  • Selective targeting of pathway-specific enzymes

  • Analysis of pathway intermediates using LC-MS/MS

  • Genetic validation using biotin auxotrophs

  • Growth phenotyping under biotin-limited conditions

Research has demonstrated the effectiveness of this approach by targeting different steps in the biotin biosynthetic pathway. The biotin pathway in E.coli involves SAM-dependent methylation in the initial step, creating interaction opportunities with methionine metabolism . Studies using inhibitors like MAC13772 targeting the antepenultimate step of biotin biosynthesis provide insights into pathway vulnerability.

When designing biotin pathway studies, researchers should:

  • Include biotin supplementation controls

  • Consider the temporal sequence of enzymatic reactions

  • Account for potential pathway compensation mechanisms

  • Integrate transcriptomic analysis to detect regulatory responses

This comprehensive approach enables detailed characterization of this essential pathway and identification of potential synergistic inhibition strategies.

How can researchers effectively study fatty acid biosynthesis in E.coli and its interconnections with other metabolic pathways?

Methodological approaches for studying fatty acid biosynthesis interconnections require:

  • Selective inhibition of condensing enzymes (e.g., FabB)

  • Membrane composition analysis using lipidomics

  • Metabolic flux analysis with labeled precursors

  • Integration with other biosynthetic pathway analyses

Research has established that β-ketoacyl-ACP synthase I (FabB), essential for fatty acid biosynthesis, also participates in elongating biotin's saturated chain moiety . This dual role highlights the interconnection between fatty acid metabolism and cofactor biosynthesis.

The experimental workflow should include:

  • Selective inhibition studies using pathway-specific compounds

  • Complementation assays with pathway intermediates

  • Membrane integrity assessment following inhibition

  • Transcriptional analysis of compensatory responses

This integrated methodological approach reveals the complex relationship between fatty acid biosynthesis and other essential pathways, providing insights into potential multi-target inhibition strategies.

What methodologies are recommended for investigating synergistic antibiotic interactions against E.coli?

Robust investigation of synergistic antibiotic interactions requires structured methodological approaches:

  • Standardized checkerboard assays with concentration matrices

  • Time-kill kinetics to distinguish bacteriostatic versus bactericidal effects

  • Mechanism of action studies to determine interaction basis

  • In vivo validation using appropriate infection models

Research has identified unexpected synergistic interactions, such as the potentiation of the typically Gram-positive antibiotic novobiocin against E.coli through combination with cell wall-active antibiotics like vancomycin and fosmidomycin . These unexpected synergies demonstrate the importance of systematic screening approaches.

When designing antibiotic interaction studies, researchers should implement:

Methodological ConsiderationImplementation Approach
Concentration range selectionInclude sub-inhibitory to fully inhibitory
Interaction quantificationCalculate fractional inhibitory concentration indices (FICI)
Temporal analysisAssess interactions at multiple timepoints
Mechanism validationPerform genetic or biochemical target confirmation

This structured approach enables identification of clinically relevant synergistic combinations and elucidation of their mechanistic basis.

How should researchers approach experimental design for studying housekeeping function inhibitors in E.coli?

Methodological approaches for studying housekeeping function inhibitors require:

  • Clear categorization of inhibitor classes based on cellular targets

  • Multi-parameter phenotypic analysis beyond growth inhibition

  • Target engagement validation through biochemical or genetic approaches

  • Consideration of conditional essentiality under different growth conditions

Research utilizing 27 housekeeping function probes demonstrated the importance of systematic interaction analysis . When studying compounds that target cell wall synthesis, protein synthesis, or DNA replication, researchers should:

  • Establish clear phenotypic readouts for each functional class

  • Include corresponding positive controls for each mechanism

  • Consider growth condition-dependent effects on target essentiality

  • Implement resistance development analysis

This comprehensive approach enables characterization of compounds affecting core cellular functions and identification of potential combination strategies to enhance antimicrobial efficacy or prevent resistance development.

Product Science Overview

Structure and Function

Methionine Aminopeptidase is a metalloenzyme, meaning it requires metal ions for its catalytic activity. The active site of MAP contains two adjacent divalent metal ions, typically cobalt (Co²⁺) or nickel (Ni²⁺), connected by a water molecule or hydroxide ion . These metal ions are essential for the enzyme’s function, as they facilitate the hydrolysis of the peptide bond at the N-terminal methionine.

Recombinant Expression in E. Coli

Recombinant expression of Methionine Aminopeptidase in Escherichia coli (E. coli) involves the insertion of the gene encoding MAP into an E. coli expression system. This allows for the production of large quantities of the enzyme for research and industrial applications. The recombinant MAP is typically fused to a His-tag at the N-terminus, which aids in its purification using affinity chromatography techniques .

Biochemical Properties

The recombinant E. coli Methionine Aminopeptidase has been characterized to have a molecular mass of approximately 31 kDa . It is a single, non-glycosylated polypeptide chain containing 284 amino acids . The enzyme exhibits high specificity for substrates with a methionine residue at the N-terminus and non-bulky, uncharged amino acids at the penultimate position .

Applications

Methionine Aminopeptidase is widely used in various biochemical and biotechnological applications. Its ability to remove the N-terminal methionine from recombinant proteins makes it valuable in protein engineering and production. Additionally, MAP is a potential target for the development of antibacterial drugs, as the NME process is essential for bacterial survival .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.